首页> 美国政府科技报告 >Examination of HFE C282Y/H63D Heterozygotes as a Potential Human Modeling System for Low Level Liver Damage
【24h】

Examination of HFE C282Y/H63D Heterozygotes as a Potential Human Modeling System for Low Level Liver Damage

机译:检测HFE C282Y / H63D杂合子作为低水平肝损伤的潜在人体模拟系统

获取原文

摘要

Individuals heterozygous for hemochromatosis gene (HFE) mutations have been shown to demonstrate mild systemic iron-loading. In some studies, mildly elevated liver enzymes are noted. More sensitive testing methodologies are needed to assist in determining which heterozygous individuals may be at risk for future deleterious effects. Alpha Glutathione-S-Transferase (AGST) has been used to determine sub-clinical liver dysfunction and damage. However, AGST has not been used to examine the potential damage caused by mild iron loading. Whole blood/serum samples from individuals 20-50 years of age were collected from the Wright Patterson AFB clinical laboratory with only age and sex indicated. Genomic DNA was isolated from anticolagulated whole blood using the GFX Genomic Blood DNA Purification Kit (Amersham Biosciences). In two reactions, Exon 2 and Exon 4 of the HFEl gene were amplified using primer sets HH63A/HH63B and HHl/HH5, respectively, in a standard PCR reaction (Accuprime PCR Kit, Invitrogen). The PCR products were digested either with MboI (Exon 2 containing the C186G mutation) or RsaI (Exon 4 containing the G845A mutation). The resultant restriction fragments were analyzed with matched controls on a 2% TBE agarose gel. Three groups of samples were identified (C282Y heterozygotes, H63D heterozygotes, and homozygous normal controls). Serum alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, iron status, and AGST were analyzed on each sample. Samples from individuals possessing heterozygous C282Y mutation did not demonstrate a statistically significant elevation in AGST or other liver enzymes when compared to samples with no mutation. Similar results were found in individuals heterozygous for the H63D mutation. These results demonstrate that AGST activity may not be a good indicator for sub-clinical liver damage caused by increased loading of hepatic iron.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号